Details for New Drug Application (NDA): 072713
✉ Email this page to a colleague
The generic ingredient in SULINDAC is sulindac. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulindac profile page.
Summary for 072713
Tradename: | SULINDAC |
Applicant: | Chartwell Rx |
Ingredient: | sulindac |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072713
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Aug 30, 1991 | TE: | RLD: | No |
Complete Access Available with Subscription